サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1463045

ヒト成長ホルモン市場、シェア、規模、動向、産業分析レポート：タイプ別、投与経路別、年齢別、適応症別、流通チャネル別、地域別、セグメント予測、2024-2032年

Human Growth Hormone Market Share, Size, Trends, Industry Analysis Report, By Type (Long-acting, Short-acting & Intermediate-acting); By Route of Administration; By Age; By Indication; By Distribution Channel; By Region; Segment Forecast, 2024- 2032

出版日
ページ情報
英文 114 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ヒト成長ホルモン市場、シェア、規模、動向、産業分析レポート：タイプ別、投与経路別、年齢別、適応症別、流通チャネル別、地域別、セグメント予測、2024-2032年
出版日: 2024年03月24日
発行: Polaris Market Research
ページ情報: 英文 114 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、ヒト成長ホルモンの世界市場規模は2032年までに156億6,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

ヒト成長ホルモン（HGH）市場の範囲は、その到達範囲、用途、影響因子を定義する様々な次元を包含します。同市場は、HGHの治療用途に対応しており、小児や成人の成長ホルモン欠乏症などの病状に対応しています。HGHは、内因性成長ホルモンの分泌が不十分な人の成長と発達を刺激するために使用されます。

市場の大部分は、成長ホルモン欠乏症による低身長のような状態を含む、小児成長障害への対応に焦点を当てています。HGH療法は、小児の直線的な成長を促進するための一般的な治療法です。同市場は成長ホルモン欠乏症を持つ成人にも拡大しており、そこではHGHがAGHDなどの病態に対処するために使用されています。これには、成人期の成長ホルモン分泌不足に関連する健康問題への対処が含まれます。市場内には、アンチエイジングやウェルネス用途に対応するセグメントも増えています。HGHは、皮膚の健康、エネルギーレベル、全体的な健康の改善など、アンチエイジング効果として認識されるために使用されることもあります。

さらに、HGHは筋肉が衰弱した状態や代謝障害の治療にも用いられています。同市場は、特定の患者集団における筋肉減少の影響を緩和し、代謝機能を改善するためのHGHの治療的使用に取り組んでいます。

成長ホルモン欠乏症（GHD）の高い有病率、GHDに関連する深刻なリスクに起因する治療の必要性の増加、および注射の頻度を減らす薬への需要の高まりは、ヒト成長ホルモン市場の成長に寄与する主な要因です。

下垂体機能不全の症例の増加や、患者の治療へのアドヒアランスを高めるためのより高度な技術の市場開拓といった要因も、市場の成長に寄与しています。ソマトロピンの強力なパイプラインと相まって、業界各社が研究開発活動に重点を置くようになっていることが、予測期間中の市場成長を促進すると予想されます。

適切な治療に関連する意識の高まりと、ヒト成長不全の治療に関連する公的および民間組織によるイニシアチブの高まりは、ヒト成長ホルモン市場の拡大にとって有益であることを証明すると予想されます。さらに、新興国全体で希少疾患に罹患する患者数が増加していることも、市場開拓に貢献するでしょう。

ヒト成長ホルモン市場レポートハイライト

長時間作用型ヒト成長ホルモンの安全性プロファイルと有効性により、長時間作用型セグメントは予測期間中に最も高いCAGRで拡大すると予測されます。

2023年には、成長ホルモン欠乏症分野が最大の市場シェアを占めたが、これは同疾患の有病率の高さとその治療のための新製品数の増加によるものです。

2023年には、病院への患者訪問数の増加により、病院薬局セグメントが最大の市場シェアを占めました。

北米は、ターナー症候群と成長ホルモン欠乏症の症例が増加しているため、2023年のヒト成長ホルモン市場で最大の収益シェアを占めました。

市場プレイヤーには、AnkeBio Co., Ltd.、Ascendis Pharma、Novo Nordisk、Pfizer、Eli Lilly、Sandoz International、Merck、Genentechなどが含まれます。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界のヒト成長ホルモン市場の洞察

  • ヒト成長ホルモン- 業界スナップショット
  • ヒト成長ホルモン市場力学
    • 促進要因と機会
      • 成長ホルモン欠乏症およびその他の疾患の罹患率の上昇
      • 研究開発活動の増加
    • 抑制要因と課題
      • 副作用と安全性の懸念
  • PESTLE分析
  • ヒト成長ホルモン業界の動向
  • COVID-19の影響分析

第5章 タイプ別の世界市場

  • 主な調査結果
  • イントロダクション
  • 長時間作用型
  • 短時間作用型と中時間作用型

第6章 投与経路別の世界市場

  • 主な調査結果
  • イントロダクション
  • 経口
  • 非経口

第7章 年齢別の世界市場

  • 主な調査結果
  • イントロダクション
  • 小児
  • 成人

第8章 流通チャネル別の世界市場

  • 主な調査結果
  • イントロダクション
  • 病院薬局
  • 小売薬局・ドラッグストア
  • オンライン薬局

第9章 適応症別の世界市場

  • 主な調査結果
  • イントロダクション
  • 成長ホルモン欠乏症
  • ターナー症候群
  • 特発性低身長
  • プラダー・ウィリー症候群
  • その他

第10章 地域別の世界市場

  • 主な調査結果
  • イントロダクション
    • ヒト成長ホルモン市場評価、地域別、2019-2032年
  • ヒト成長ホルモン市場-北米
    • 北米：ヒト成長ホルモン市場、タイプ別、2019-2032年
    • 北米：ヒト成長ホルモン市場、流通チャネル別、2019年～2032年
    • 北米：ヒト成長ホルモン市場、投与経路別、2019年～2032年
    • 北米：ヒト成長ホルモン市場、年齢別、2019年～2032年
    • 北米：ヒト成長ホルモン市場、適応症別、2019年～2032年
    • ヒト成長ホルモン市場-米国
    • ヒト成長ホルモン市場- カナダ
  • ヒト成長ホルモン市場- 欧州
    • 欧州：ヒト成長ホルモン市場、タイプ別、2019-2032年
    • 欧州：ヒト成長ホルモン市場、流通チャネル別、2019-2032年
    • 欧州：ヒト成長ホルモン市場、投与経路別、2019年～2032年
    • 欧州：ヒト成長ホルモン市場、年齢別、2019-2032年
    • 欧州：ヒト成長ホルモン市場、適応症別、2019-2032年
    • ヒト成長ホルモン市場- 英国
    • ヒト成長ホルモン市場- フランス
    • ヒト成長ホルモン市場- ドイツ
    • ヒト成長ホルモン市場- イタリア
    • ヒト成長ホルモン市場- スペイン
    • ヒト成長ホルモン市場- オランダ
    • ヒト成長ホルモン市場- ロシア
  • ヒト成長ホルモン市場- アジア太平洋地域
    • アジア太平洋地域：ヒト成長ホルモン市場、タイプ別、2019年～2032年
    • アジア太平洋地域：ヒト成長ホルモン市場、流通チャネル別、2019年～2032年
    • アジア太平洋地域：ヒト成長ホルモン市場、投与経路別、2019年～2032年
    • アジア太平洋地域：ヒト成長ホルモン市場、年齢別、2019年～2032年
    • アジア太平洋地域：ヒト成長ホルモン市場、適応症別、2019年～2032年
    • ヒト成長ホルモン市場- 中国
    • ヒト成長ホルモン市場- インド
    • ヒト成長ホルモン市場- 日本
    • ヒト成長ホルモン市場- マレーシア
    • ヒト成長ホルモン市場- インドネシア
    • ヒト成長ホルモン市場- 韓国
  • ヒト成長ホルモン市場-中東およびアフリカ
    • 中東およびアフリカ：ヒト成長ホルモン市場、タイプ別、2019-2032年
    • 中東およびアフリカ：ヒト成長ホルモン市場、流通チャネル別、2019-2032年
    • 中東およびアフリカ：ヒト成長ホルモン市場、投与経路別、2019-2032年
    • 中東およびアフリカ：ヒト成長ホルモン市場、年齢別、2019-2032年
    • 中東およびアフリカ：ヒト成長ホルモン市場、適応症別、2019-2032年
    • ヒト成長ホルモン市場- サウジアラビア
    • ヒト成長ホルモン市場-UAE
    • ヒト成長ホルモン市場- イスラエル
    • ヒト成長ホルモン市場- 南アフリカ
  • ヒト成長ホルモン市場-ラテンアメリカ
    • ラテンアメリカ：ヒト成長ホルモン市場、タイプ別、2019-2032年
    • ラテンアメリカ：ヒト成長ホルモン市場、流通チャネル別、2019-2032年
    • ラテンアメリカ：ヒト成長ホルモン市場、投与経路別、2019年～2032年
    • ラテンアメリカ：ヒト成長ホルモン市場、年齢別、2019年～2032年
    • ラテンアメリカ：ヒト成長ホルモン市場、適応症別、2019年～2032年
    • ヒト成長ホルモン市場- メキシコ
    • ヒト成長ホルモン市場- ブラジル
    • ヒト成長ホルモン市場- アルゼンチン

第11章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • パートナーシップ/コラボレーション/契約/公開

第12章 企業プロファイル

  • AnkeBio Co., Ltd
  • Ascendis Pharma
  • Eli Lilly and Company
  • Ferring Pharmaceuticals
  • Genentech, Inc（Roche）
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk
  • Pfizer Inc.
  • Sandoz International GmbH
図表

List of Tables

  • Table 1 Global Human Growth Hormone Market, by Type, by Region, 2019-2032 (USD Billion)
  • Table 2 Global Human Growth Hormone Market, by Route of Administration, by Region, 2019-2032 (USD Billion)
  • Table 3 Global Human Growth Hormone Market, by Age, by Region, 2019-2032 (USD Billion)
  • Table 4 Global Human Growth Hormone Market, by Indication, by Region, 2019-2032 (USD Billion)
  • Table 5 Global Human Growth Hormone Market, by Distribution Channel, by Region, 2019-2032 (USD Billion)
  • Table 6 North America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 7 North America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 8 North America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 9 North America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 10 North America: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 11 U.S.: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 12 U.S.: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 13 U.S.: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 14 U.S.: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 15 U.S.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 16 Canada: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 17 Canada: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 18 Canada: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 19 Canada: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 20 Canada: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 21 Europe: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 22 Europe: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 23 Europe: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 24 Europe: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 25 Europe: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 26 Germany: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 27 Germany: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 28 Germany: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 29 Germany: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 30 Germany: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 31 France: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 32 France: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 33 France: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 34 France: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 35 France: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 36 UK: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 37 UK: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 38 UK: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 39 UK: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 40 UK: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 41 Italy: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 42 Italy: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 43 Italy: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 44 Italy: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 45 Italy: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 46 Netherlands: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 47 Netherlands: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 48 Netherlands: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 49 Netherlands: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 50 Netherlands: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 51 Spain: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 52 Spain: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 53 Spain: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 54 Spain: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 55 Spain: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 56 Russia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 57 Russia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 58 Russia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 59 Russia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 60 Russia: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 61 Asia Pacific: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 62 Asia Pacific: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 63 Asia Pacific: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 64 Asia Pacific: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 65 Asia Pacific: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 66 China: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 67 China: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 68 China: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 69 China: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 70 China: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 71 Japan: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 72 Japan: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 73 Japan: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 74 Japan: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 75 Japan: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 76 India: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 77 India: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 78 India: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 79 India: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 80 India: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 81 Indonesia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 82 Indonesia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 83 Indonesia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 84 Indonesia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 85 Indonesia: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 86 Malaysia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 87 Malaysia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 88 Malaysia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 89 Malaysia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 90 Malaysia: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 91 South Korea: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 92 South Korea: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 93 South Korea: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 94 South Korea: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 95 South Korea: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 96 Latin America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 97 Latin America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 98 Latin America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 99 Latin America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 100 Latin America: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 101 Brazil: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 102 Brazil: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 103 Brazil: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 104 Brazil: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 105 Brazil: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 106 Mexico: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 107 Mexico: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 108 Mexico: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 109 Mexico: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 110 Mexico: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 111 Argentina: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 112 Argentina: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 113 Argentina: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 114 Argentina: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 115 Argentina: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 116 Middle East & Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 117 Middle East & Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 118 Middle East & Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 119 Middle East & Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 120 Middle East & Africa: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 121 UAE: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 122 UAE: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 123 UAE: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 124 UAE: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 125 UAE: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 126 Saudi Arabia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 127 Saudi Arabia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 128 Saudi Arabia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 129 Saudi Arabia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 130 Saudi Arabia: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 131 South Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 132 South Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 133 South Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 134 South Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 135 South Africa: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • Table 136 Israel: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • Table 137 Israel: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • Table 138 Israel: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • Table 139 Israel: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • Table 140 Israel: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)

List of Figures

  • Figure 1. Global Human Growth Hormone Market, 2019-2032 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Human Growth Hormone Market, by Type, 2021 & 2030 (USD Billion)
  • Figure 8. Market by Route of Administration
  • Figure 9. Global Human Growth Hormone Market, by Route of Administration, 2021 & 2030 (USD Billion)
  • Figure 10. Market by Age
  • Figure 11. Global Human Growth Hormone Market, by Age, 2021 & 2030 (USD Billion)
  • Figure 12. Market by Indication
  • Figure 13. Global Human Growth Hormone Market, by Indication, 2021 & 2030 (USD Billion)
  • Figure 14. Market by Distribution Channel
  • Figure 15. Global Human Growth Hormone Market, by Distribution Channel, 2021 & 2030 (USD Billion)
目次
Product Code: PM4705

The global human growth hormone market size is expected to reach USD 15.66 billion by 2032, according to a new study by Polaris Market Research. The report "Human Growth Hormone Market Share, Size, Trends, Industry Analysis Report, By Type (Long-acting, Short-acting & Intermediate-acting); By Route of Administration; By Age; By Indication; By Distribution Channel; By Region; Segment Forecast, 2023- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The scope of the Human Growth Hormone (HGH) market encompasses various dimensions that define its reach, applications, and influencing factors. The market caters to therapeutic applications of HGH, addressing medical conditions such as growth hormone deficiencies in children and adults. HGH is used to stimulate growth and development in individuals with insufficient endogenous growth hormone production.

A significant portion of the market focuses on addressing pediatric growth disorders, including conditions like short stature due to growth hormone deficiencies. HGH therapy is a common intervention to promote linear growth in children. The market extends its scope to adults with growth hormone deficiencies, where HGH is used to address conditions such as AGHD. This involves addressing health issues associated with insufficient growth hormone production in adulthood. There is a growing segment within the market that caters to anti-aging and wellness applications. HGH is sometimes used for its perceived anti-aging effects, including improvements in skin health, energy levels, and overall well-being.

Furthermore, HGH is employed in the treatment of muscle-wasting conditions and metabolic disorders. The market addresses the therapeutic use of HGH to mitigate the effects of muscle loss and improve metabolic functions in certain patient populations.

The high prevalence of growth hormone deficiency (GHD), the increasing need for treatment owing to serious risks associated with GHD, and the rising demand for medications that reduce the frequency of injections are the major factors contributing to the growth of the human growth hormone market.

Factors such as increasing cases of pituitary dysfunction and the development of more advanced technologies to enhance patient adherence to the treatment contribute to the market growth. The rising emphasis of industry players on research & development activities coupled with the strong pipeline of somatropin is expected to drive the market growth during the forecast period.

Increasing awareness related to appropriate treatment coupled with the growing initiatives by public and private organizations related to the treatment of human growth deficiency are expected to prove beneficial for the expansion of the human growth hormone market. Moreover, the increasing number of patients suffering from rare diseases across developing countries will also contribute to the market growth.

Human Growth Hormone Market Report Highlights

The long-acting segment is projected to expand at the highest CAGR during the forecast period, owing to the safety profile & effectiveness of long-acting human growth hormones.

In 2023, the growth hormone deficiency segment accounted for the largest market share, owing to the high prevalence of the disease and the rising number of new products for its treatment.

In 2023, the hospital pharmacies segment accounted for the largest market share, owing to the increasing number of patient visits to hospitals.

North America accounted for the largest revenue share in the human growth hormone market in 2023, owing to the rising cases of Turner syndrome and growth hormone deficiencies.

The market players include AnkeBio Co., Ltd, Ascendis Pharma, Novo Nordisk, Pfizer, Eli Lilly, Sandoz International, Merck, Genentech, and more.

Polaris Market Research has segmented the human growth hormone market report based on type, route of administration, age, indication, distribution channel, and region:

Human Growth Hormone, Type Outlook (Revenue - USD Billion, 2019 - 2032)

  • Long-acting
  • Short-acting & Intermediate-acting

Human Growth Hormone, Route of Administration Outlook (Revenue - USD Billion, 2019 - 2032)

  • Oral
  • Parenteral
  • Intravenous
  • Subcutaneous
  • Intramuscular

Human Growth Hormone, Age Outlook (Revenue - USD Billion, 2019 - 2032)

  • Pediatric
  • Adult

Human Growth Hormone, Indication Outlook (Revenue - USD Billion, 2019 - 2032)

  • Growth Hormone Deficiency
  • Turner Syndrome
  • Idiopathic Short Stature
  • Prader-Willi Syndrome
  • Others

Human Growth Hormone, Distribution Channel Outlook (Revenue - USD Billion, 2019 - 2032)

  • Hospital Pharmacies
  • Retail Pharmacies & Drug Stores
  • Online Pharmacies

Human Growth Hormone, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of APAC
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of LA
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of MEA

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Human Growth Hormone Market Insights

  • 4.1. Human Growth Hormone - Industry Snapshot
  • 4.2. Human Growth Hormone Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Growth Hormone Deficiency and Other Disorders
      • 4.2.1.2. Growing Number of Research & Development Activities
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Side Effects and Safety Concerns
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Human Growth Hormone Industry Trends
  • 4.6. COVID-19 Impact Analysis

5. Global Human Growth Hormone Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
  • 5.3. Long-acting
    • 5.3.1. Global Human Growth Hormone Market, by Long-acting, by Region, 2019-2032 (USD Billion)
  • 5.4. Short-acting & Intermediate-acting
    • 5.4.1. Global Human Growth Hormone Market, by Short-acting & Intermediate-acting, by Region, 2019-2032 (USD Billion)

6. Global Human Growth Hormone Market, by Route of Administration

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
  • 6.3. Oral
    • 6.3.1. Global Human Growth Hormone Market, by Oral, by Region, 2019-2032 (USD Billion)
  • 6.4. Parenteral
    • 6.4.1. Global Human Growth Hormone Market, by Parenteral, by Region, 2019-2032 (USD Billion)
    • 6.4.2. Intravenous
      • 6.4.2.1. Global Human Growth Hormone Market, by Intravenous, by Region, 2019-2032 (USD Billion)
    • 6.4.3. Subcutaneous
      • 6.4.3.1. Global Human Growth Hormone Market, by Subcutaneous, by Region, 2019-2032 (USD Billion)
    • 6.4.4. Intramuscular
      • 6.4.4.1. Global Human Growth Hormone Market, by Intramuscular, by Region, 2019-2032 (USD Billion)

7. Global Human Growth Hormone Market, by Age

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
  • 7.3. Pediatric
    • 7.3.1. Global Human Growth Hormone Market, by Pediatric, by Region, 2019-2032 (USD Billion)
  • 7.4. Adult
    • 7.4.1. Global Human Growth Hormone Market, by Adult, by Region, 2019-2032 (USD Billion)

8. Global Human Growth Hormone Market, by Distribution Channel

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
  • 8.3. Hospital Pharmacies
    • 8.3.1. Global Human Growth Hormone Market, by Hospital Pharmacies, by Region, 2019-2032 (USD Billion)
  • 8.4. Retail Pharmacies & Drug Stores
    • 8.4.1. Global Human Growth Hormone Market, by Retail Pharmacies & Drug Stores, by Region, 2019-2032 (USD Billion)
  • 8.5. Online Pharmacies
    • 8.5.1. Global Human Growth Hormone Market, by Online Pharmacies, by Region, 2019-2032 (USD Billion)

9. Global Human Growth Hormone Market, by Indication

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 9.3. Growth Hormone Deficiency
    • 9.3.1. Global Human Growth Hormone Market, by Growth Hormone Deficiency, by Region, 2019-2032 (USD Billion)
  • 9.4. Turner Syndrome
    • 9.4.1. Global Human Growth Hormone Market, by Turner Syndrome, by Region, 2019-2032 (USD Billion)
  • 9.5. Idiopathic Short Stature
    • 9.5.1. Global Human Growth Hormone Market, by Idiopathic Short Stature, by Region, 2019-2032 (USD Billion)
  • 9.6. Prader-Willi Syndrome
    • 9.6.1. Global Human Growth Hormone Market, by Prader-Willi Syndrome, by Region, 2019-2032 (USD Billion)
  • 9.7. Others
    • 9.7.1. Global Human Growth Hormone Market, by Others, by Region, 2019-2032 (USD Billion)

10. Global Human Growth Hormone Market, by Geography

  • 10.1. Key findings
  • 10.2. Introduction
    • 10.2.1. Human Growth Hormone Market Assessment, By Geography, 2019-2032 (USD Billion)
  • 10.3. Human Growth Hormone Market - North America
    • 10.3.1. North America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.3.2. North America: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.3.3. North America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.3.4. North America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.3.5. North America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.3.6. Human Growth Hormone Market - U.S.
      • 10.3.6.1. U.S.: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.3.6.2. U.S.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.3.6.3. U.S.: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.6.4. U.S.: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.3.6.5. U.S.: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.3.7. Human Growth Hormone Market - Canada
      • 10.3.7.1. Canada: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.3.7.2. Canada.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.3.7.3. Canada: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.3.7.4. Canada: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.3.7.5. Canada: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.4. Human Growth Hormone Market - Europe
    • 10.4.1. Europe: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.4.2. Europe.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.4.3. Europe: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.4.4. Europe: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.4.5. Europe: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.6. Human Growth Hormone Market - UK
      • 10.4.6.1. UK: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.6.2. UK.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.6.3. UK: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.6.4. UK: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.6.5. UK: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.7. Human Growth Hormone Market - France
      • 10.4.7.1. France: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.7.2. France.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.7.3. France: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.7.4. France: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.7.5. France: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.8. Human Growth Hormone Market - Germany
      • 10.4.8.1. Germany: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.8.2. Germany.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.8.3. Germany: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.8.4. Germany: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.8.5. Germany: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.9. Human Growth Hormone Market - Italy
      • 10.4.9.1. Italy: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.9.2. Italy.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.9.3. Italy: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.9.4. Italy: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.9.5. Italy: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.10. Human Growth Hormone Market - Spain
      • 10.4.10.1. Spain: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.10.2. Spain.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.10.3. Spain: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.10.4. Spain: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.10.5. Spain: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.11. Human Growth Hormone Market - Netherlands
      • 10.4.11.1. Netherlands: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.11.2. Netherlands.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.11.3. Netherlands: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.11.4. Netherlands: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.11.5. Netherlands: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.4.12. Human Growth Hormone Market - Russia
      • 10.4.12.1. Russia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.4.12.2. Russia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.4.12.3. Russia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.4.12.4. Russia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.4.12.5. Russia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.5. Human Growth Hormone Market - Asia Pacific
    • 10.5.1. Asia Pacific: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.5.2. Asia Pacific.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.5.3. Asia Pacific: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.5.4. Asia Pacific: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.5.5. Asia Pacific: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.6. Human Growth Hormone Market - China
      • 10.5.6.1. China: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.6.2. China.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.6.3. China: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.6.4. China: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.6.5. China: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.7. Human Growth Hormone Market - India
      • 10.5.7.1. India: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.7.2. India.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.7.3. India: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.7.4. India: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.7.5. India: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.8. Human Growth Hormone Market - Japan
      • 10.5.8.1. Japan: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.8.2. Japan.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.8.3. Japan: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.8.4. Japan: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.8.5. Japan: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.9. Human Growth Hormone Market - Malaysia
      • 10.5.9.1. Malaysia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.9.2. Malaysia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.9.3. Malaysia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.9.4. Malaysia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.9.5. Malaysia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.10. Human Growth Hormone Market - Indonesia
      • 10.5.10.1. Indonesia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.10.2. Indonesia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.10.3. Indonesia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.10.4. Indonesia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.10.5. Indonesia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.5.11. Human Growth Hormone Market - South Korea
      • 10.5.11.1. South Korea: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.5.11.2. South Korea.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.5.11.3. South Korea: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.5.11.4. South Korea: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.5.11.5. South Korea: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.6. Human Growth Hormone Market - Middle East & Africa
    • 10.6.1. Middle East & Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.6.2. Middle East & Africa: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.6.3. Middle East & Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.6.4. Middle East & Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.6.5. Middle East & Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.6. Human Growth Hormone Market - Saudi Arabia
      • 10.6.6.1. Saudi Arabia: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.6.2. Saudi Arabia.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.6.3. Saudi Arabia: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.6.4. Saudi Arabia: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.6.5. Saudi Arabia: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.7. Human Growth Hormone Market - UAE
      • 10.6.7.1. UAE: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.7.2. UAE.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.7.3. UAE: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.7.4. UAE: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.7.5. UAE: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.8. Human Growth Hormone Market - Israel
      • 10.6.8.1. Israel: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.8.2. Israel.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.8.3. Israel: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.8.4. Israel: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.8.5. Israel: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.6.9. Human Growth Hormone Market - South Africa
      • 10.6.9.1. South Africa: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.6.9.2. South Africa.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.6.9.3. South Africa: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.6.9.4. South Africa: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.6.9.5. South Africa: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
  • 10.7. Human Growth Hormone Market - Latin America
    • 10.7.1. Latin America: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
    • 10.7.2. Latin America.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
    • 10.7.3. Latin America: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
    • 10.7.4. Latin America: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
    • 10.7.5. Latin America: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.7.6. Human Growth Hormone Market - Mexico
      • 10.7.6.1. Mexico: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.7.6.2. Mexico.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.7.6.3. Mexico: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.6.4. Mexico: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.7.6.5. Mexico: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.7.7. Human Growth Hormone Market - Brazil
      • 10.7.7.1. Brazil: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.7.7.2. Brazil.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.7.7.3. Brazil: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.7.4. Brazil: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.7.7.5. Brazil: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)
    • 10.7.8. Human Growth Hormone Market - Argentina
      • 10.7.8.1. Argentina: Human Growth Hormone Market, by Type, 2019-2032 (USD Billion)
      • 10.7.8.2. Argentina.: Human Growth Hormone Market, by Distribution Channel, 2019-2032 (USD Billion)
      • 10.7.8.3. Argentina: Human Growth Hormone Market, by Route of Administration, 2019-2032 (USD Billion)
      • 10.7.8.4. Argentina: Human Growth Hormone Market, by Age, 2019-2032 (USD Billion)
      • 10.7.8.5. Argentina: Human Growth Hormone Market, by Indication, 2019-2032 (USD Billion)

11. Competitive Landscape

  • 11.1. Expansion and Acquisition Analysis
    • 11.1.1. Expansion
    • 11.1.2. Acquisitions
  • 11.2. Partnerships/Collaborations/Agreements/Exhibitions

12. Company Profiles

  • 12.1. AnkeBio Co., Ltd
    • 12.1.1. Company Overview
    • 12.1.2. Financial Performance
    • 12.1.3. Product Benchmarking
    • 12.1.4. Recent Development
  • 12.2. Ascendis Pharma
    • 12.2.1. Company Overview
    • 12.2.2. Financial Performance
    • 12.2.3. Product Benchmarking
    • 12.2.4. Recent Development
  • 12.3. Eli Lilly and Company
    • 12.3.1. Company Overview
    • 12.3.2. Financial Performance
    • 12.3.3. Product Benchmarking
    • 12.3.4. Recent Development
  • 12.4. Ferring Pharmaceuticals
    • 12.4.1. Company Overview
    • 12.4.2. Financial Performance
    • 12.4.3. Product Benchmarking
    • 12.4.4. Recent Development
  • 12.5. Genentech, Inc (Roche)
    • 12.5.1. Company Overview
    • 12.5.2. Financial Performance
    • 12.5.3. Product Benchmarking
    • 12.5.4. Recent Development
  • 12.6. Merck KGaA
    • 12.6.1. Company Overview
    • 12.6.2. Financial Performance
    • 12.6.3. Product Benchmarking
    • 12.6.4. Recent Development
  • 12.7. Novartis AG
    • 12.7.1. Company Overview
    • 12.7.2. Financial Performance
    • 12.7.3. Product Benchmarking
    • 12.7.4. Recent Development
  • 12.8. Novo Nordisk
    • 12.8.1. Company Overview
    • 12.8.2. Financial Performance
    • 12.8.3. Product Benchmarking
    • 12.8.4. Recent Development
  • 12.9. Pfizer Inc.
    • 12.9.1. Company Overview
    • 12.9.2. Financial Performance
    • 12.9.3. Product Benchmarking
    • 12.9.4. Recent Development
  • 12.10. Sandoz International GmbH
    • 12.10.1. Company Overview
    • 12.10.2. Financial Performance
    • 12.10.3. Product Benchmarking
    • 12.10.4. Recent Development